Boston Scientific (BSX) Cash from Investing Activities Growth (3y) (2012 - 2026)
Boston Scientific (BSX) Cash from Investing Activities Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 17.83% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | -6.23% |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | -24.52% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | -32.54% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | -68.12% |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 37.39% |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | -11.04% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 19.58% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | -17.67% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 7.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32.54% |
| Mar 31, 2026 | -6.88% |
| Dec 31, 2025 | -40.91% |
| Sep 30, 2025 | -30.67% |
| Jun 30, 2025 | -238.62% |
| Mar 31, 2025 | 31.77% |
| Dec 31, 2024 | -100.29% |
| Sep 30, 2024 | -5.74% |
| Mar 31, 2024 | -81.85% |
| Dec 31, 2023 | -92.77% |
| Sep 30, 2023 | -15.16% |
| Jun 30, 2023 | -142.37% |
| Mar 31, 2023 | -85.36% |
| Dec 31, 2022 | -55.15% |
| Sep 30, 2022 | 61.56% |
| Jun 30, 2022 | 63.97% |
| Mar 31, 2022 | -56.58% |
| Dec 31, 2021 | 8.15% |
| Sep 30, 2021 | -22.17% |
| Mar 31, 2021 | 34.08% |